DYLAN TIMMERMANN: Open Payments
NPI 1235838228 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,414 in 121 payments from 18 companies in 2025. Trend: 2023 $698 · 2024 $3,856 · 2025 $14,414
Speaker / faculty: $9,600Food & beverage: $2,896Consulting: $1,125Travel & lodging: $498Education: $295
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 43 | $10,790 |
| Incyte Corporation | 8 | $1,373 |
| LEO Pharma Inc. | 7 | $661 |
| Arcutis Biotherapeutics, Inc. | 8 | $389 |
| Janssen Biotech, Inc. | 9 | $278 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $184 |
| ABBVIE INC. | 12 | $153 |
| Lilly USA, LLC | 5 | $135 |
| UCB, Inc. | 7 | $109 |
| Regeneron Healthcare Solutions, Inc. | 2 | $101 |
Products named: AKLIEF, DYSPORT, ADBRY, Zoryve, NEMLUVIO, TREMFYA, OPZELURA, DUPIXENT.
Industry payments across KS — which companies pay providers there.
